Technology | Magnetic Resonance Imaging (MRI) | October 02, 2017

Siemens Healthineers Debuts Magnetom Vida RT Pro Edition MRI at ASTRO 2017

New 3T MRI scanner offers intuitive, dedicated radiation therapy planning workflows and enables consistent patient scanning in treatment position

Siemens Healthineers Debuts Magnetom Vida RT Pro Edition MRI at ASTRO 2017

October 2, 2017 — Siemens Healthineers debuted the Magnetom RT Pro edition of Magnetom Vida, a version of the company’s 3T magnetic resonance imaging (MRI) scanner designed for radiation therapy (RT) planning, at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San Diego. The scanner features the new BioMatrix Technology, which overcomes unwanted variability by addressing the inherent anatomical and physiological differences of patients. It includes a comprehensive package of hardware and software that supports optimal treatment planning.

In addition to an all-new magnet, the Magnetom RT Pro edition for Magnetom Vida features a new system architecture designed for extremely high performance and long-term stability. This system architecture includes an optional 60/200 XT gradient system that has the potential to reduce geometric distortion. And the scanner’s 55x55x50 field of view (FOV) enables coverage of larger body regions in a single step.

Additionally, the scanner’s RT Dot Engine provides a comprehensive set of MR protocols that enable accurate, reproducible coordinates and slice orientations. The RT Dot engine predefines RT strategies, automatically corrects for image distortion to improve spatial integrity, and automatically reconstructs axial images to enable direct processing of all data in RT planning software. It also provides laser quality assurance to maintain a high level of accuracy in patient positioning.

Additionally, the scanner’s RESOLVE software reduces distortions associated with MR diffusion by a factor of three, helping to ensure accurate dose planning for the linear accelerator. RESOLVE also enables delivery of sharp images at a higher spatial resolution.

For more information: www.usa.healthcare.siemens.com

Related Content

Global radiotherapy market revenue is set to expand from $7,222.4 million in 2019 to $17,194.4 million by 2030, at an 8.4% CAGR between 2020 and 2030, the key factor driving the market growth is the increasing number of cancer cases, according to the report published by P&S Intelligence.

Image courtesy of Elekta

News | Radiation Therapy | August 06, 2020
August 6, 2020 — Global ...
Imaging volumes in hospitals and practices previously slowed by the coronavirus pandemic continue to hold steady, according to new QuickPoLL survey results that gauge how radiologists feel about current business and the impact of COVID-19.
Feature | Coronavirus (COVID-19) | August 03, 2020 | By Melinda Taschetta-Millane
Imaging volumes in hospitals and practices previously slowed by the coronavirus pandemic continue to hold steady, acc
Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG’s acquisition of a 100 percent stake in Varian Medical Systems, Inc., a U.S. company active in the area of cancer research and therapy.

Getty Images

News | Radiology Business | August 03, 2020
August 3, 2020 — Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly wel
Franco Fontana, CEO of the Esaote Group, and Xie Yufeng, Chairman of WDM.

Franco Fontana, CEO of the Esaote Group, and Xie Yufeng, Chairman of WDM.

News | Digital Radiography (DR) | July 31, 2020
July 31, 2020 — In the thick of the COVID-19 eme
JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

Table 1. JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

News | Coronavirus (COVID-19) | July 31, 2020
July 31, 2020 — An article published in JAMA...
It covers every major modality, including breast imaging/mammography, fixed and portable C-arms (cath, IR/angio, hybrid, OR), CT, MRI, nuclear medicine, radiographic fluoroscopy, ultrasound and X-ray
News | Radiology Imaging | July 29, 2020
July 29, 2020 — IMV Medical Information, part of Scien...
It has been estimated that the overwhelming focus on COVID-19 could cause up to 35,000 excess cancer deaths in the UK during the next 12 months, and  Zegami, the Oxford University data visualization spin-out which has worked on several projects focused on the detection, diagnosis, or management of cancer, is calling for greater use of technology to speed up the process of diagnosis and treatment.

Getty Images

News | Radiation Oncology | July 29, 2020
July 29, 2020 — It has been estimated that the overwhelming focus on...
In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.  http://jnm.snmjournals.org/content/early/2020/07/16/jnumed.120.249748.full.pdf+html

In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.

 

News | Coronavirus (COVID-19) | July 22, 2020 | Dave Fornell, Editor
July 22, 2020 — One of the first studies has been published that looks at the use of...